Key result
LVAD bridge to transplantation linked to ~32% higher 1-year posttransplant mortality versus medical management.
Why the study?
Does bridge to transplantation with LVADs impact posttransplantation mortality in adult heart transplant recipients compared to medical management?
Cohort (n=5,486)
Yes
Does bridge to transplantation with LVADs impact posttransplantation mortality in adult heart transplant recipients compared to medical management?
Answers are grounded in this paper and cite their sources.
Bridge to heart transplantation with an LVAD is associated with higher early posttransplantation mortality compared to medical management, especially in patients with renal dysfunction or higher BMI.
Background: Bridge to transplantation (BTT) with left ventricular assist devices (LVADs) is a mainstay of therapy for heart failure in patients awaiting heart transplantation (HT). Criteria for HT listing do not differ between patients medically managed and those mechanically bridged to HT. The objectives of the present study were to evaluate the impact of BTT with LVAD on posttransplantation survival, to describe differences in causes of 1-year mortality in medically and mechanically bridged patients, and to evaluate differences in risk factors for 1-year mortality between those with and those without LVAD at the time of HT. Methods: Using the United Network of Organ Sharing database, we identified 5486 adult, single-organ HT recipients transplanted between 2008 and 2015. Patients were propensity matched for likelihood of LVAD at the time of HT. Kaplan–Meier survival estimates were used to assess the impact of BTT on 1- and 5-year mortality. Logistic regression analysis was used to evaluate the odds ratio of 1-year mortality for patients BTT with LVAD compared with those with medical management across clinically significant variables at various thresholds. Results: Early mortality was higher in mechanically bridged patients: 9.5% versus 7.2% mortality at 1 year ( P <0.001). BTT patients incurred an increased risk of 1-year mortality with an estimated glomerular filtration rate of 40 to 60 mL·min −1 ·1.73 m −2 (odds ratio, 1.69; P =0.003) and <40 mL·min −1 ·1.73 m −2 (odds ratio, 2.16; P =0.005). A similar trend was seen in patients with a body mass index of 25 to 30 kg/m 2 (odds ratio, 1.88; P =0.024) and >30 kg/m 2 (odds ratio, 2.11; P <0.001). When patients were stratified by BTT status and the presence of risk factors, including age >60 years, estimated glomerular filtration rate <40 mL·min −1 ·1.73 m −2 , and body mass index >30 kg/m 2 , there were significant differences in 1-year mortality between medium- and high-risk medically and mechanically bridged patients, with 1-year mortality in high-risk BTT patients at 17.6% compared with 10.4% in high-risk medically managed patients. Conclusions: Bridge to HT with LVAD, although necessary because of organ scarcity and capable of improving wait list survival, confers a significantly higher risk of early posttransplantation mortality. Patients bridged with mechanical support may require more careful consideration for transplant eligibility after LVAD placement.
No takes yet. Share an insight, caveat, or question.
Truby et al. (2019) conducted a cohort in Heart failure awaiting heart transplantation (n=5,486). Bridge to transplantation with left ventricular assist devices (LVADs) vs. Medical management was evaluated on 1-year mortality (p=<0.001). Bridge to transplantation with left ventricular assist devices was associated with higher 1-year posttransplantation mortality compared with medical management.
Synapse has enriched 10 related papers. Consider them for comparative context: